OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen
He‐Wen Wang, Ke-Ling Ma, Hua Liu, et al.
Aging (2020) Vol. 12, Iss. 7, pp. 6018-6029
Open Access | Times Cited: 8
He‐Wen Wang, Ke-Ling Ma, Hua Liu, et al.
Aging (2020) Vol. 12, Iss. 7, pp. 6018-6029
Open Access | Times Cited: 8
Showing 8 citing articles:
Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
Sepideh Mirzaei, Mohammad Gholami, Farid Hashemi, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 2, pp. 436-455
Open Access | Times Cited: 134
Sepideh Mirzaei, Mohammad Gholami, Farid Hashemi, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 2, pp. 436-455
Open Access | Times Cited: 134
Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
ACS Combinatorial Science (2020) Vol. 22, Iss. 12, pp. 669-700
Open Access | Times Cited: 84
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
ACS Combinatorial Science (2020) Vol. 22, Iss. 12, pp. 669-700
Open Access | Times Cited: 84
Triptolide promotes ferroptosis by suppressing Nrf2 to overcome leukemia cell resistance to doxorubicin
Xia Wu, Shangqing Chen, Ke‐Chu Huang, et al.
Molecular Medicine Reports (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 19
Xia Wu, Shangqing Chen, Ke‐Chu Huang, et al.
Molecular Medicine Reports (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 19
Nanoscale strategies: doxorubicin resistance challenges and enhancing cancer therapy with advanced nanotechnological approaches
Jian Xin Lim, Yoke Keong Yong, Firli Rahmah Primula Dewi, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Jian Xin Lim, Yoke Keong Yong, Firli Rahmah Primula Dewi, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Transferrin-Targeted Cascade Nanoplatform for Inhibiting Transcription Factor Nuclear Factor Erythroid 2-Related Factor 2 and Enhancing Ferroptosis Anticancer Therapy
Wenjie Chen, Li Xie, Can Lv, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 24, pp. 28879-28890
Closed Access | Times Cited: 6
Wenjie Chen, Li Xie, Can Lv, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 24, pp. 28879-28890
Closed Access | Times Cited: 6
Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies
Tom C. Karagiannis, Meaghan Wall, Katherine Ververis, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 9
Closed Access | Times Cited: 4
Tom C. Karagiannis, Meaghan Wall, Katherine Ververis, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 9
Closed Access | Times Cited: 4
Research Progress of Naturally Originated Potential Drugs on Reversing Drug Resistance in Malignant Tumors
Xiaolan Deng, Xuelong Chen, Fuling Li, et al.
Indian Journal of Pharmaceutical Sciences (2024) Vol. 86, Iss. S2
Open Access
Xiaolan Deng, Xuelong Chen, Fuling Li, et al.
Indian Journal of Pharmaceutical Sciences (2024) Vol. 86, Iss. S2
Open Access
Encapsulation for general cancer treatment
Elmira Zolali, Sina Rashedi, Elaheh Dalir Abdolahinia, et al.
Elsevier eBooks (2023), pp. 589-660
Closed Access
Elmira Zolali, Sina Rashedi, Elaheh Dalir Abdolahinia, et al.
Elsevier eBooks (2023), pp. 589-660
Closed Access
